Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient Carcinoma

Integrase interactor 1 (INI‐1)‐deficient carcinoma is a rare cancer characterized by the loss of the SWItch/Sucrose Non‐Fermentable‐related matrix‐associated actin‐dependent regulator of chromatin subfamily B member 1 gene (SMARCB1) and tends to follow an aggressive clinical course. There is no curr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Karantanos, Theodoros, Rooper, Lisa, Kang, Youme, Lin, Cheng Ting, Wenga, Pawla, Sagorsky, Sarah, Lauring, Josh, Kang, Hyunseok
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2018
Ämnen:
Precision Medicine Clinic: Molecular Tumor Board
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369939/
https://ncbi.nlm.nih.gov/pubmed/30297384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0279
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk